US Patent Issued to CANCER RESEARCH TECHNOLOGIES on July 21 for "Methods and compositions for gamma-glutamyl cycle modulation" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,667, issued on July 21, was assigned to CANCER RESEARCH TECHNOLOGIES LLC (Las Vegas).

"Methods and compositions for gamma-glutamyl cycle modulation" was invented by David Rubin (San Diego) and Eyal Rubin (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides pharmaceutical compositions comprising Gamma-glutamyl cycle inhibitors (GGCI) and certain pharmaceutically acceptable salts thereof, and methods of use."

The patent was filed on Nov. 29, 2021, under Application No. 17/537,266.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect...